Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
Active & ResponsiveNew
Effect of Meal Timing During Adjuvant Treatment for Cancer
for
Cancer
Location: Los Angeles CA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT07524218
Recruiting
Active & ResponsiveNew
Tensi+ for Treating Overactive Bladder
for
Overactive Bladder (OAB)
Location: Beverly Hills CA, Toronto, New York NY
Sponsor: Stimuli Technology
Sex: All
Age: 22+
Code: NCT07300904
Recruiting
Active & Responsive
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
for
Tachycardia, Ventricular
Location: Los Angeles CA, Columbia MO, Rochester MN, St Louis MO,
Sponsor: Varian, a Siemens Healthineers Company
Sex: All
Age: 18+
Code: NCT05765175
Recruiting
Active & Responsive
Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy
for
Chronic Maxillary Rhinosinusitis
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT06567821
Phase2, Phase3, Recruiting
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Los Angeles CA, San Diego CA, Aurora CO, Seattle WA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: Los Angeles CA, Denver CO, Katy TX, Winston-Salem NC,
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
for
Glioblastoma, IDH-Wildtype
Location: Los Angeles CA, Madison WI, Menomonee Falls WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06319027
Phase2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: Los Angeles CA, Palo Alto CA, Salt Lake City UT,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase2, Recruiting
Active & Responsive
Family Foundations for Individuals Pregnant Via ART
for
Assisted Reproductive Technology
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: Female
Age: 18+
Code: NCT06770972
Recruiting
Active & Responsive
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
for
Advanced Solid Tumor
Location: Beverly Hills CA, Houston TX, Pittsburgh PA
Sponsor: Strand Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06249048
Phase1, Phase2, Recruiting
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Beverly Hills CA, Santa Monica CA, West Hills CA,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase2, Recruiting
Active & Responsive
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC),
Location: Los Angeles CA, Fort Worth TX
Sponsor: iLeukon Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07452224
Phase2, Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
for
Idiopathic Hypersomnia
Location: Morrisville NC, Santa Monica CA, Peoria AZ,
Sponsor: Harmony Biosciences Management, Inc.
Sex: All
Age: 18+
Code: NCT07500090
Phase3, Recruiting
Active & ResponsiveNew
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
for
Metastatic Urothelial Carcinoma,
Location: Los Angeles CA, Spokane WA
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07815665
Phase2, Phase3, Recruiting
Active & Responsive
Writing About Experiences and Health in Older Adults II
for
Social Psychology
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 65+
Code: NCT05524597
Phase1, Recruiting
Active & Responsive
This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal
for
Nuclear Sclerosis of the Lens,
Location: Los Angeles CA
Sponsor: Nicole Fram M.D.
Sex: All
Age: 18+
Code: NCT07468877
Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: Beverly Hills CA, Westlake Village CA, Los Gatos CA,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
for
Polycythemia Vera
Location: Redlands CA, Salt Lake City UT, Eugene OR, Englewood CO,
Sponsor: Italfarmaco
Sex: All
Age: 18+
Code: NCT06093672
Phase3, Recruiting
Active & Responsive
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: West Hollywood CA, Omaha NE
Sponsor: Oncotherapeutics
Sex: All
Age: 0+
Code: NCT06115135
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma